Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker. [electronic resource]
Producer: 20090211Description: 2841-6 p. digitalISSN:- 1460-2385
- Administration, Inhalation
- Angiotensin II -- blood
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Benzazepines -- pharmacology
- Double-Blind Method
- Female
- Humans
- Hypertension -- blood
- Kidney -- drug effects
- Kidney Diseases -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Tetrazoles -- pharmacology
- Transforming Growth Factor beta1
- Valine -- analogs & derivatives
- Valsartan
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.